Hypoxia regulates human mast cell adhesion to fibronectin via the PI3K/AKT signaling pathway

Cell Adh Migr. 2020 Dec;14(1):106-117. doi: 10.1080/19336918.2020.1764690.

Abstract

A decrease in oxygen concentration is a hallmark of inflammatory reactions resulting from infection or homeostasis disorders. Mast cells interact with extracellular matrix and other cells by adhesion receptors. We investigated the effect of hypoxia on integrin-mediated mast cell adhesion to fibronectin. We found that it was mediated by the α5/β1 receptor and that hypoxia significantly upregulated this process. Hypoxia-mediated increases in mast cell adhesion occurred without increased surface expression of integrins, suggesting regulation by inside-out integrin signaling. Hypoxia also mediated an increase in phosphorylation of Akt, and PI3'kinase inhibitors abolished hypoxia-mediated mast cell adhesion. Hypoxia upregulates the function of integrin receptors by PI3' kinase-dependent signaling. This process might be important for the location of mast cells at inflammatory sites.

Keywords: AKT; LAD2; Mast cells; PI3K; SCF; adhesion; fibronectin; hypoxia; integrin α5β1; wortmannin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion / drug effects
  • Cell Hypoxia / drug effects
  • Cell Line
  • Fibronectins / pharmacology*
  • Humans
  • Integrin alpha5beta1 / metabolism
  • Mast Cells / cytology*
  • Mast Cells / drug effects
  • Mast Cells / enzymology*
  • Oligopeptides / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphatidylinositol 3-Kinases / pharmacology
  • Phosphoinositide-3 Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Receptors, Cell Surface / metabolism
  • Signal Transduction* / drug effects
  • Stem Cell Factor / pharmacology
  • Wortmannin / pharmacology

Substances

  • Fibronectins
  • Integrin alpha5beta1
  • Oligopeptides
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Receptors, Cell Surface
  • Stem Cell Factor
  • arginyl-glycyl-aspartic acid
  • Proto-Oncogene Proteins c-akt
  • Wortmannin

Grants and funding

This work was supported by the National Science Centre grant no. 2015/17/B/NZ6/04252.